MR Analysis of the Substantia Innominata in Normal Aging, Alzheimer Disease, and Other Types of Dementia

References

1. ↵
   Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122–126

   CrossRefPubMedWeb of Science
2. ↵
   Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237–1239

   Abstract/FREE Full Text
3. ↵
   Sasaki M, Ehara S, Tamakawa Y, et al MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary study. AJNR Am J Neuroradiol 1995;16:2001–2007

   Abstract
4. ↵
   McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944

   Abstract/FREE Full Text
5. ↵
   Hachinski VC, Iliff LD, Zilhka E, et al Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637

   CrossRefPubMedWeb of Science
6. ↵
   Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198

   CrossRefPubMedWeb of Science
7. ↵
   Roman GC, Tatemichi TK, Erkinjuntti T, et al Vascular dementia, diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260

   Abstract/FREE Full Text
8. ↵
   Clinical and neuropathological criteria for frontotemporal dementia: Lund and Manchester groups. J Neurol Neurosurg Psychiatry 1994;57:416–418

   FREE Full Text
9. ↵
   McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T. Aging, Alzheimer’s disease, and the cholinergic system of the basal forebrain. Neurology 1984;34:741–745

   Abstract/FREE Full Text
10. ↵
    Mann DMA, Yates PO, Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer’s disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Aging Dev 1984;25:189–204
11. ↵
    Lowes-Hummel P, Gertz HJ, Ferszt R, Cervos-Navarro J. The basal nucleus of Meynert revised: the nerve cell number decreases with age. Arch Gerontol Geriatr 1989;8:21–27

    CrossRefPubMedWeb of Science
12. ↵
    De Lacalle S, Iraizoz I, Ma Gonzalo L. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging. Neuroscience 1991;43:445–456

    CrossRefPubMedWeb of Science
13. ↵
    Chui HC, Bondareff W, Zarow C, Slager U. Stability of neuronal number in the human nucleus basalis of Meynert with age. Neurobiol Aging 1984;5:83–88

    CrossRefPubMedWeb of Science
14. ↵
    Whitehouse PJ, Parhad IM, Hedreen JC, et al. Integrity of the nucleus basalis of Meynert in normal aging. Neurology 1983;33:159
15. ↵
    Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman C Choline acetyltransferase immunohistochemistry in brains of Alzheimer’s disease patients and controls. Neurosci Lett 1983;36:195–199

    CrossRefPubMedWeb of Science
16. Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s disease. Acta Neuropathol (Berl) 1983;61:101–108

    CrossRefPubMed
17. Pearson RCA, Sofroniew MV, Cuello AC, et al Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer’s type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 1983;289:375–379

    CrossRefPubMedWeb of Science
18. Rinne JO, Paljarvi L, Rinne UK. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer’s disease. J Neurol Sci 1987;79:67–76

    CrossRefPubMedWeb of Science
19. Allen SJ, Dawbarn D, Wilcock GK. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer’s disease. Brain Res 1988;454:275–281

    CrossRefPubMed
20. ↵
    Vogels OJM, Broere CAJ, Ter Laak HJ, Ten Donkelaar HJ, Nieuwenhuys R, Schulte BPM. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer’s disease. Neurobiol Aging 1990;11:3–13

    CrossRefPubMedWeb of Science
21. ↵
    Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, Paralysis agitans and Korsakoff’s disease. Acta Neuropathol (Berl) 1983;61:101–108
22. ↵
    Whitehouse PJ, Hedreen JC, White CL III, Price DL. Basal forebrain neurons in the dementia of Parkinson’s disease. Ann Neurol 1983;13:243–248.

    CrossRefPubMedWeb of Science
23. ↵
    Nakano I, Hirano A. Neuron loss in the nucleus basalis of Meynert of Parkinsonism-dementia complex of Guam. Ann Neurol 1983;13:87–91

    CrossRefPubMedWeb of Science
24. ↵
    Arendt T, Bigl V, Arendt A. Neuron loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl) 1984;65:85–88

    CrossRefPubMed
25. ↵
    Tagliavini F, Pilleri G, Gemignani F, Lechi A. Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy. Acta Neuropathol (Berl) 1983;61:157–160

    CrossRefPubMed
26. ↵
    Uhl G, Hilt DC, Hedreen JC, Whitehouse PJ, Price DL. Pick’s disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology 1983;33:1470–1473

    Abstract/FREE Full Text
27. ↵
    Price DL, Whitehouse PJ, Struble RG, et al Alzheimer’s disease and Down’s syndrome. Ann NY Acad Sci 1982;396:145–164

    PubMedWeb of Science
28. ↵
    Kato T, Hirano A, Katagiri T, Sasaki H, Yamada S. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann Neurol 1988;23:620–623

    CrossRefPubMedWeb of Science
29. ↵
    Perry EK, Haroutunian V, Davis KL, et al Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer’s disease. Neuroreport 1994;5:747–749

    PubMedWeb of Science
30. ↵
    Ruberg M, Ploska A, Javoy-Agid F, Agid Y. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia. Brain Res 1982;232:129–139

    CrossRefPubMedWeb of Science
31. ↵
    Sparks DL, Markesbery WR. Altered serotonergic and cholinergic synaptic markers in Pick’s disease. Arch Neurol 1991;41:796–799
32. ↵
    Gottfries CG, Blennow K, Karlsson I, Wallin A. The neurochemistry of vascular dementia. Dementia 1994;5:163–167
33. ↵
    Schenker C, Meier D, Wichmann W, Boesiger P, Valavanis A. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119–124

    CrossRefPubMedWeb of Science
34. ↵
    Bartzokis G, Sultzer D, Mintz J, et al In vivo evaluation of brain iron in Alzheimer’s disease and normal subjects using MRI. Biol Psychiatry 1994;35:480–487

    CrossRefPubMedWeb of Science
35. ↵
    Constrable RT, Anderson AW, Zhong J, Gore JC. Factors influencing contrast in fast spin-echo MR imaging. Magn Reson Imaging 1992;10:497–511

    CrossRefPubMed